Orion Oyj
Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.
ORNAV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009014377 (+1 more)
- LEI:
- 74370029VAHCXDR7B745
- Country:
- Finland
- Address:
- Orionintie 1, FI-02200 ESPOO
- Website:
- https://www.orion.fi/en/
- Sector:
- Manufacturing
Description
Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-07-05 09:10 |
200,000 Orion A-shares converted into B-shares
|
English | 1.0 KB | ||
| 2012-07-03 13:35 |
Orion upgrades full-year outlook for 2012
|
English | 2.2 KB | ||
| 2012-05-01 14:00 |
U.S. District Court gives decision on Precedex® patent litigation
|
English | 2.8 KB | ||
| 2012-05-01 14:00 |
Alioikeus antoi päätöksensä Orionin Precedex®-alkuperälääkettä koskevassa U.S.-…
|
Finnish | 2.9 KB | ||
| 2012-04-26 17:25 |
Orion haastaa oikeuteen Mylan-yhtiön Yhdysvalloissa puolustaakseen Stalevo® -al…
|
Finnish | 3.3 KB | ||
| 2012-04-26 17:25 |
Orion sues Mylan in the U.S. to enforce its U.S. patents covering the proprieta…
|
English | 3.1 KB | ||
| 2012-04-10 07:45 |
Orion invites analysts and media to Q1 news conference on Tuesday 24 April 2012
|
English | 2.5 KB | ||
| 2012-04-10 07:45 |
Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 2…
|
Finnish | 2.6 KB | ||
| 2012-03-26 07:01 |
Orion kommentoi Stalevo®-alkuperälääkkeen geneeristä versiota koskevaa Mylan P…
|
Finnish | 3.4 KB | ||
| 2012-03-26 07:01 |
Orion comments on ANDA filed by Mylan Pharmaceuticals Inc. for a generic versio…
|
English | 3.2 KB | ||
| 2012-03-20 14:30 |
Orion Oyj : Decisions by the AGM on 20 March 2012
|
English | 5.0 KB | ||
| 2012-03-20 14:30 |
Orion Oyj : Varsinaisen yhtiökokouksen päätökset 20.3.2012
|
Finnish | 4.6 KB | ||
| 2012-03-12 16:45 |
Orion Corporation: Transfer of 87,763 own B-shares on 12 March 2012
|
English | 2.4 KB | ||
| 2012-03-12 16:45 |
Orion Oyj: 87 763 oman B-osakkeen luovutus 12.3.2012
|
Finnish | 2.2 KB | ||
| 2012-03-06 09:36 |
Orion Group Annual Report 2011 published
|
English | 746.0 KB |
Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orion Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orion Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
